Cargando…
Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling
We previously reported that autocrine TNF-α (TNF) is responsible for JNK pathway activation in a subset of acute myeloid leukemia (AML) patient samples, providing a survival/proliferation signaling parallel to NF-κB in AML stem cells (LSCs). In this study, we report that most TNF-expressing AML cell...
Autores principales: | Li, Jing, Volk, Andrew, Zhang, Jun, Cannova, Joseph, Dai, Shaojun, Hao, Caiqin, Hu, Chenglong, Sun, Jiewen, Xu, Yan, Wei, Wei, Breslin, Peter, Nand, Sucha, Chen, Jianjun, Kini, Ameet, Zhu, Jiang, Zhang, Jiwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352411/ https://www.ncbi.nlm.nih.gov/pubmed/28039479 http://dx.doi.org/10.18632/oncotarget.14220 |
Ejemplares similares
-
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
por: Volk, Andrew, et al.
Publicado: (2014) -
Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis
por: Joshi, Kanak, et al.
Publicado: (2022) -
The Synergistic Repressive Effect of NF-κB and JNK Inhibitor on the Clonogenic Capacity of Jurkat Leukemia Cells
por: Liu, Xinli, et al.
Publicado: (2014) -
Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo
por: Guo, Qi, et al.
Publicado: (2018) -
The Clinical Significance of PR, ER, NF-κB, and TNF-α in Breast Cancer
por: Zhou, Xian-Long, et al.
Publicado: (2014)